期刊文献+

益气活血解毒方对小鼠卵巢癌ID-8细胞株增殖及血管生成过程的影响 被引量:11

Effect of Yiqi Huoxue Jiedu Decoction on Proliferation of Ovarian Cancer ID-8 Cells and Angiogenesis
原文传递
导出
摘要 目的:研究益气活血解毒方抑制鼠卵巢上皮癌ID-8细胞株增殖的作用,并观察本方对于脐静脉内皮细胞(HUVECs)形成血管过程的作用,为本方发挥疗效提供实验依据。方法:采用细胞增殖与检测方法(cell counting kit-8,CCK-8)检测本方对于ID-8细胞增殖的抑制作用;将含中药血清、磁珠分选的调节性T细胞(regulatory T cells,Tregs)与抗血管内皮生长因子(VEGF)抗体分组共培养,观察血管生成情况差异。结果:与空白组比较,10%,20%含药血清均能够抑制卵巢上皮癌ID-8细胞株的增殖,此抑制作用在培养96 h时最明显;在72,96 h时,20%含药血清组的抑制率明显高于10%含药血清组(P〈0.05,P〈0.01)。与Tregs(-)各组相比,Tregs(+)各组HUVECs细胞呈现明显的血管网状结构,中药含药血清组血管成网不明显,VEGF抗体联合含药血清组血管成网情况最差。结论:益气活血解毒方对小鼠卵巢上皮癌ID-8细胞株的增殖过程有显著的抑制作用,同时能够干预血管的形成,这也许与本方影响Tregs促进肿瘤新生血管的作用相关。 Objective: To analyze the inhibitory effects of Yiqi Huoxue Jiedu decoction on proliferation of ovarian epithelial carcinoma ID-8 cells in vitro,observe the effect of this method on angiogenesis of human umbilical vein endothelial cells(HUVECs),and provide experimental basis for its efficacy.Method: Cell counting kit-8(CCK-8) was used to testify the inhibitory effect of Yiqi Huoxue Jiedu decoction on the proliferation of ovarian cancer ID-8 cells; decoction serum,regulatory T cells(Tregs) isolated by immune magnetic MACS Micro Beads,as well as vascular endothelial growth factors(VEGF) were co-cultured,and then the angiogenesis of HUVEC was observed.Result: As compared with blank control group(fetal bovine serum group),drug serum groups with concentration of 10% and 20% showed inhibitory effects on ID-8 cells,and this effect was most significant at 96 h.Serum group with concentration of 20% showed remarkable advantages against 10% group at72 h(P 〈0.01) and 96 h(P〈0.05).HUVECs cultivated with Treg cells exhibited a better angiogenesis process.On the other hand,the vascular network was not obvious in drug serum group,and the inhibitory effect was most significant in anti-VEGF + Yiqi Huoxue Jiedu decoction.Conclusion: Yiqi Huoxue Jiedu decoction can restrict the multiplication of ovarian epithelial carcinoma ID-8 cells,and it could intervene the angiogenesis of HUVECs,which is probably associated with the intervention on Tregs.
出处 《中国实验方剂学杂志》 CAS CSCD 北大核心 2018年第4期154-159,共6页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家自然科学基金项目(81473566)
关键词 益气活血解毒方 卵巢癌 ID-8细胞株 调节T细胞 肿瘤血管 Yiqi Huoxue Jiedu decoction ovarian cancer ID-8 regulatory T cells tumor angiogenesis
  • 相关文献

参考文献4

二级参考文献66

  • 1陈良良,梁华.中医药免疫调节治疗恶性肿瘤研究进展[J].中国中医药信息杂志,2004,11(9):839-841. 被引量:17
  • 2Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
  • 3Spannuth WA,Sood AK,Coleman RL.Angiogenesis as a strategic target for ovarian cancer therapy[J].Nat Clin Pract Oncol,2008,5(4):194-204.
  • 4Siddiqui GK,Elmasry K,Wong Te Fong AC,et al.Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer[J].Eur J Gynaecol Oncol,2010,31(2):156-159.
  • 5Garcia AA,Hirte H,Fleming G,et al.PhaseⅡclinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer:a trial of the California,Chicago,and Princess Margaret Hospital phaseⅡconsortia[J].J Clin Oncol,2008,26(1):76-82.
  • 6Brown JV 3rd,Micha JP,Rettenmaier MA,et al.A pilot study evaluating a novel regimen comprised of carboplatin,paclitaxel,and bevacizumab for advanced-stage ovarian carcinoma[J].Int J Gynecol Cancer,2010,20(7):1132-1136.
  • 7Kobold S,Hegewisch-Becker S,Oechsle K,et al.Intraperitoneal VEGF inhibition using bevacizumab:a potential approach for the symptomatic treatment of malignant ascites?[J].Oncologist,2009,14(12):1242-1251.
  • 8Sfakianos GP,Numnum TM,Halverson CB,et al.The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy:a retrospective cohort study[J].Gynecol Oncol,2009,114(3):424-426.
  • 9Bull Phelps SL,Schorge JO,Peyton MJ,et al.Implications of EGFR inhibition in ovarian cancer cell proliferation[J].Gynecol Oncol,2008,109(3):411-417.
  • 10Heyerdahl H,Krogh C,Borrebaek J,et al.Treatment of HER2expressing breast cancer and ovarian cancer cells with alpha particleemitting 227Th-trastuzumab[J].Int J Radiat Oncol Biol Phys,2011,79(2):563-570.

共引文献32

同被引文献208

引证文献11

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部